Berberine stimulates lysosomal AMPK independent of PEN2 and maintains cellular AMPK activity through inhibiting the dephosphorylation regulator UHRF1
Aim: AMPK is the key regulatory kinase mediating the effect of berberine (BBR) and metformin on metabolic improvement. The present study investigated the mechanism of BBR on AMPK activation at low doses, which was different from that of metformin.Methods: Lysosomes were isolated, and AMPK activity a...
Main Authors: | Gang Ren, Yu-Wei Ding, Lu-Lu Wang, Jian-Dong Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1148611/full |
Similar Items
-
The Metformin Mechanism on Gluconeogenesis and AMPK Activation: The Metabolite Perspective
by: Loranne Agius, et al.
Published: (2020-05-01) -
Novel UHRF1-MYC Axis in Acute Lymphoblastic Leukemia
by: Soyoung Park, et al.
Published: (2022-08-01) -
Metformin protects fibroblasts from patients with GNE myopathy by restoring autophagic flux via an AMPK/mTOR-independent pathway
by: Tongtong Zhang, et al.
Published: (2023-08-01) -
Liposome-Encapsulated Berberine Alleviates Liver Injury in Type 2 Diabetes via Promoting AMPK/mTOR-Mediated Autophagy and Reducing ER Stress: Morphometric and Immunohistochemical Scoring
by: Safaa I. Khater, et al.
Published: (2023-06-01) -
The UHRF1 protein is a key regulator of retrotransposable elements and innate immune response to viral RNA in human cells
by: RE Irwin, et al.
Published: (2023-12-01)